Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1992 May;36(5):949–954. doi: 10.1128/aac.36.5.949

Therapy of experimental meningitis due to Salmonella enteritidis.

J P Bryan 1, W M Scheld 1
PMCID: PMC188779  PMID: 1510418

Abstract

In many areas of the developing world, Salmonella spp. account for greater than 50% of the gram-negative enteric organisms isolated from cerebrospinal fluid (CSF). The response of Salmonella meningitis to conventional therapy (chloramphenicol and/or ampicillin) is slow, complications arise frequently, and mortality rates of 60 to 80% are common. Two newer agents, ceftriaxone and imipenem, were compared with ampicillin, chloramphenicol, and trimethoprim-sulfamethoxazole (TMP-SMX) in the therapy of experimental Salmonella meningitis beginning 14 h after intracisternal inoculation and continued by constant intravenous infusion for 8 h. Drug concentrations in serum and CSF closely approximated those achieved in the sera and CSF of humans receiving standard parenteral regimens. Penetration into purulent CSF [(concentration of drug in CSF/concentration of drug in serum) x 100] ranged from 18 to 41%. The rate of bacterial killing in CSF was significantly (P less than 0.001) more rapid during therapy with ceftriaxone and imipenem than it was during therapy with chloramphenicol or TMP-SMX. Ceftriaxone and imipenem sterilized the CSF of six of seven animals at 8 h, whereas it sterilized the CSF of three of eight animals treated with ampicillin (P = 0.18), one of eight animals treated with chloramphenicol, and none of seven animals treated with TMP-SMX (P less than or equal to 0.01; ceftriaxone or imipenem versus chloramphenicol or TMP-SMX). New beta-lactams, including ceftriaxone and imipenem, appear to be effective therapy against Salmonella spp. in this animal model and deserve further evaluation in humans.

Full text

PDF
949

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adler S. P., Markowitz S. M. Failure of moxalactam in the treatment of neonatal sepsis and meningitis from Salmonella typhimurium. J Pediatr. 1983 Dec;103(6):913–916. doi: 10.1016/s0022-3476(83)80713-6. [DOI] [PubMed] [Google Scholar]
  2. Anton P. A., Kemp J. A., Butler T., Jacobs M. R. Comparative efficacies of ceftriaxone, moxalactam, and ampicillin in experimental Salmonella typhimurium infection. Antimicrob Agents Chemother. 1982 Aug;22(2):312–315. doi: 10.1128/aac.22.2.312. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Appelbaum P. C., Scragg J. Salmonella meningitis in infants. Lancet. 1977 May 14;1(8020):1052–1053. doi: 10.1016/s0140-6736(77)91280-6. [DOI] [PubMed] [Google Scholar]
  4. Barza M. Imipenem: first of a new class of beta-lactam antibiotics. Ann Intern Med. 1985 Oct;103(4):552–560. doi: 10.7326/0003-4819-103-4-552. [DOI] [PubMed] [Google Scholar]
  5. Bryan J. P., Rocha H., Scheld W. M. Problems in salmonellosis: rationale for clinical trials with newer beta-lactam agents and quinolones. Rev Infect Dis. 1986 Mar-Apr;8(2):189–207. doi: 10.1093/clinids/8.2.189. [DOI] [PubMed] [Google Scholar]
  6. Bryan J. P., Rocha H., da Silva H. R., Taveres A., Sande M. A., Scheld W. M. Comparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitis. Antimicrob Agents Chemother. 1985 Sep;28(3):361–368. doi: 10.1128/aac.28.3.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bryan J. P., de Silva H. R., Tavares A., Rocha H., Scheld W. M. Etiology and mortality of bacterial meningitis in northeastern Brazil. Rev Infect Dis. 1990 Jan-Feb;12(1):128–135. doi: 10.1093/clinids/12.1.128. [DOI] [PubMed] [Google Scholar]
  8. Cherubin C. E., Marr J. S., Sierra M. F., Becker S. Listeria and gram-negative bacillary meningitis in New York City, 1972-1979. Frequent causes of meningitis in adults. Am J Med. 1981 Aug;71(2):199–209. doi: 10.1016/0002-9343(81)90106-6. [DOI] [PubMed] [Google Scholar]
  9. Congeni B. L., Bradley J., Hammerschlag M. R. Safety and efficacy of once daily ceftriaxone for the treatment of bacterial meningitis. Pediatr Infect Dis. 1986 May-Jun;5(3):293–297. doi: 10.1097/00006454-198605000-00004. [DOI] [PubMed] [Google Scholar]
  10. Dacey R. G., Sande M. A. Effect of probenecid on cerebrospinal fluid concentrations of penicillin and cephalosporin derivatives. Antimicrob Agents Chemother. 1974 Oct;6(4):437–441. doi: 10.1128/aac.6.4.437. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Emejuru O., Jayam-Trouth A. Salmonella meningitis in infancy. J Natl Med Assoc. 1988 Jul;80(7):824-5, 829. [PMC free article] [PubMed] [Google Scholar]
  12. Forster J. Chloramphenicol treatment of childhood bacterial meningitis. Lancet. 1989 Jul 15;2(8655):161–161. doi: 10.1016/s0140-6736(89)90218-3. [DOI] [PubMed] [Google Scholar]
  13. Goossens H., Vanhoof R., De Mol P., Grados O., Ghysels G., Butzler J. P. In-vitro susceptibility of salmonellae to antimicrobial agents. J Antimicrob Chemother. 1984 Jun;13(6):559–565. doi: 10.1093/jac/13.6.559. [DOI] [PubMed] [Google Scholar]
  14. Hadfield T. L., Monson M. H., Wachsmuth I. K. An outbreak of antibiotic-resistant Salmonella enteritidis in Liberia, West Africa. J Infect Dis. 1985 May;151(5):790–795. doi: 10.1093/infdis/151.5.790. [DOI] [PubMed] [Google Scholar]
  15. Islam A., Butler T., Nath S. K., Alam N. H., Stoeckel K., Houser H. B., Smith A. L. Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol. J Infect Dis. 1988 Oct;158(4):742–747. doi: 10.1093/infdis/158.4.742. [DOI] [PubMed] [Google Scholar]
  16. Joos B., Luethy R., Muehlen E., Siegenthaler W. Variability of ceftriaxone pharmacokinetics in hospitalized patients with severe infections. Am J Med. 1984 Oct 19;77(4C):59–62. [PubMed] [Google Scholar]
  17. Kinsella T. R., Yogev R., Shulman S. T., Gilmore R., Chadwick E. G. Treatment of Salmonella meningitis and brain abscess with the new cephalosporins: two case reports and a review of the literature. Pediatr Infect Dis J. 1987 May;6(5):476–480. doi: 10.1097/00006454-198705000-00014. [DOI] [PubMed] [Google Scholar]
  18. Levitz R. E., Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med. 1984 Jun;100(6):881–890. doi: 10.7326/0003-4819-100-6-881. [DOI] [PubMed] [Google Scholar]
  19. MacDonald K. L., Cohen M. L., Hargrett-Bean N. T., Wells J. G., Puhr N. D., Collin S. F., Blake P. A. Changes in antimicrobial resistance of Salmonella isolated from humans in the United States. JAMA. 1987 Sep 18;258(11):1496–1499. [PubMed] [Google Scholar]
  20. Murphy T. F., Fernald G. W. Trimethoprim-sulfamethoxazole therapy for relapses of Salmonella meningitis. Pediatr Infect Dis. 1983 Nov-Dec;2(6):465–468. doi: 10.1097/00006454-198311000-00013. [DOI] [PubMed] [Google Scholar]
  21. Nahata M. C., Powell D. A. Simultaneous determination of chloramphenicol and its succinate ester by high-performance liquid chromatography. J Chromatogr. 1981 Apr 10;223(1):247–251. doi: 10.1016/s0378-4347(00)80095-x. [DOI] [PubMed] [Google Scholar]
  22. Neu H. C. Cephalosporins in the treatment of meningitis. Drugs. 1987;34 (Suppl 2):135–153. doi: 10.2165/00003495-198700342-00011. [DOI] [PubMed] [Google Scholar]
  23. Neu H. C. The new beta-lactamase-stable cephalosporins. Ann Intern Med. 1982 Sep;97(3):408–419. doi: 10.7326/0003-4819-97-3-408. [DOI] [PubMed] [Google Scholar]
  24. Odio C. M., Faingezicht I., Paris M., Nassar M., Baltodano A., Rogers J., Sáez-Llorens X., Olsen K. D., McCracken G. H., Jr The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis. N Engl J Med. 1991 May 30;324(22):1525–1531. doi: 10.1056/NEJM199105303242201. [DOI] [PubMed] [Google Scholar]
  25. Patamasucon P., McCracken G. H., Jr Pharmacokinetics and bacteriological efficacy of N-formimidoyl thienamycin in experimental Escherichia coli meningitis. Antimicrob Agents Chemother. 1982 Mar;21(3):390–392. doi: 10.1128/aac.21.3.390. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Peltola H., Anttila M., Renkonen O. V. Randomised comparison of chloramphenicol, ampicillin, cefotaxime, and ceftriaxone for childhood bacterial meningitis. Finnish Study Group. Lancet. 1989 Jun 10;1(8650):1281–1287. doi: 10.1016/s0140-6736(89)92685-8. [DOI] [PubMed] [Google Scholar]
  27. Preblud S. R., Gill C. J., Campos J. M. Bactericidal activities of chloramphenicol and eleven other antibiotics against Salmonella spp. Antimicrob Agents Chemother. 1984 Mar;25(3):327–330. doi: 10.1128/aac.25.3.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Riley L. W., Ceballos B. S., Trabulsi L. R., Fernandes de Toledo M. R., Blake P. A. The significance of hospitals as reservoirs for endemic multiresistant Salmonella typhimurium causing infection in urban Brazilian children. J Infect Dis. 1984 Aug;150(2):236–241. doi: 10.1093/infdis/150.2.236. [DOI] [PubMed] [Google Scholar]
  29. Robins-Browne R. M., Rowe B., Ramsaroop R., Naran A. D., Threlfall E. J., Ward L. R., Lloyd D. A., Mickel R. E. A hospital outbreak of multiresistant Salmonella typhimurium belonging to phage type 193. J Infect Dis. 1983 Feb;147(2):210–216. doi: 10.1093/infdis/147.2.210. [DOI] [PubMed] [Google Scholar]
  30. Rodriguez K., Dickinson G. M., Greenman R. L. Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin. South Med J. 1985 Jun;78(6):731–732. doi: 10.1097/00007611-198506000-00028. [DOI] [PubMed] [Google Scholar]
  31. Rodriguez R. E., Valero V., Watanakunakorn C. Salmonella focal intracranial infections: review of the world literature (1884-1984) and report of an unusual case. Rev Infect Dis. 1986 Jan-Feb;8(1):31–41. doi: 10.1093/clinids/8.1.31. [DOI] [PubMed] [Google Scholar]
  32. Sakata Y., McCracken G. H., Jr, Thomas M. L., Olsen K. D. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicillin- and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antimicrob Agents Chemother. 1984 Jan;25(1):29–32. doi: 10.1128/aac.25.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Schaad U. B., McCracken G. H., Jr, Loock C. A., Thomas M. L. Pharmacokinetics and bacteriological efficacy of moxalactam (LY127935), netilmicin, and ampicillin in experimental gram-negative enteric bacillary meningitis. Antimicrob Agents Chemother. 1980 Mar;17(3):406–411. doi: 10.1128/aac.17.3.406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Schaad U. B., Suter S., Gianella-Borradori A., Pfenninger J., Auckenthaler R., Bernath O., Cheseaux J. J., Wedgwood J. A comparison of ceftriaxone and cefuroxime for the treatment of bacterial meningitis in children. N Engl J Med. 1990 Jan 18;322(3):141–147. doi: 10.1056/NEJM199001183220301. [DOI] [PubMed] [Google Scholar]
  35. Scheld W. M., Keeley J. M., Field M. R., Brodeur J. P. Co-trimoxazole versus nafcillin in the therapy of experimental meningitis due to Staphylococcus aureus. J Antimicrob Chemother. 1987 May;19(5):647–658. doi: 10.1093/jac/19.5.647. [DOI] [PubMed] [Google Scholar]
  36. Scheld W. M., Rocha H., Sande M. A., Bryan J. P. Rationale for clinical trials evaluating ceftriaxone in the therapy of bacterial meningitis. Am J Med. 1984 Oct 19;77(4C):42–49. [PubMed] [Google Scholar]
  37. Schlech W. F., 3rd, Ward J. I., Band J. D., Hightower A., Fraser D. W., Broome C. V. Bacterial meningitis in the United States, 1978 through 1981. The National Bacterial Meningitis Surveillance Study. JAMA. 1985 Mar 22;253(12):1749–1754. [PubMed] [Google Scholar]
  38. Smith A. L., Smith D. H. Improved enzymatic assay of chloramphenicol. Clin Chem. 1978 Sep;24(9):1452–1457. [PubMed] [Google Scholar]
  39. Ti T. Y., Monteiro E. H., Lam S., Lee H. S. Ceftriaxone therapy in bacteremic typhoid fever. Antimicrob Agents Chemother. 1985 Oct;28(4):540–543. doi: 10.1128/aac.28.4.540. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Tunkel A. R., Wispelwey B., Scheld W. M. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med. 1990 Apr 15;112(8):610–623. doi: 10.7326/0003-4819-112-8-610. [DOI] [PubMed] [Google Scholar]
  41. West S. E., Goodkin R., Kaplan A. M. Neonatal salmonella meningitis complicated by cerebral abscesses. West J Med. 1977 Aug;127(2):142–145. [PMC free article] [PubMed] [Google Scholar]
  42. Wilner E. C., Fenichel G. M. Treatment of salmonella meningitis. Clin Proc Child Hosp Dist Columbia. 1969 Dec;25(11):362–366. [PubMed] [Google Scholar]
  43. Wilson R., Feldman R. A. From the Centers for Disease Control. Reported isolates of Salmonella from cerebrospinal fluid in the United States, 1968--1979. J Infect Dis. 1981 Mar;143(3):504–506. doi: 10.1093/infdis/143.3.504. [DOI] [PubMed] [Google Scholar]
  44. Wong V. K., Wright H. T., Jr, Ross L. A., Mason W. H., Inderlied C. B., Kim K. S. Imipenem/cilastatin treatment of bacterial meningitis in children. Pediatr Infect Dis J. 1991 Feb;10(2):122–125. doi: 10.1097/00006454-199102000-00009. [DOI] [PubMed] [Google Scholar]
  45. del Rio M. A., Chrane D., Shelton S., McCracken G. H., Jr, Nelson J. D. Ceftriaxone versus ampicillin and chloramphenicol for treatment of bacterial meningitis in children. Lancet. 1983 Jun 4;1(8336):1241–1244. doi: 10.1016/s0140-6736(83)92696-x. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES